» Articles » PMID: 175527

MCF-7; a Human Breast Cancer Cell Line with Estrogen, Androgen, Progesterone, and Glucocorticoid Receptors

Overview
Journal Steroids
Publisher Elsevier
Specialty Biochemistry
Date 1975 Dec 1
PMID 175527
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified receptors for glucocorticoids, progestins, and androgens in a human breast tumor cell line (MCF-7) known to have estrogen receptor. Sucrose density gradients show that MCF-7 cytosol contains approximately 100 fm/mg protein estradiol (E2-3H) receptor, more than 300 fm/mg protein progesterone receptor (measured with R5020-3H), about 40 fm/mg protein 5alpha-dihydrotestosterone (5alpha-DHT-3H) receptor, and 800 fm/mg glucocorticoid receptor (measured with dexamethasone-3H). Dissociation constants obtained by Scatchard analyses were approximately 0.6 x 10(-10)M (E2), 1 x 10(-9)M (R5020), 2.8 x 10(-10)M (5alpha-DHT) and 8 x 10(-9)M (dexamethasone). No cross competition was found for estrogen receptor, but progestins competed for androgen and glucocorticoid binding. The androgen, but not the glucocorticoid, partially competed for R5020 binding to progesterone receptor. This first demonstration of 4 classes of steroid receptors in human breast cancer means that MCF-7 may be an excellent in vitro model for studying the mechanism of tumor response to endocrine therapy as well as the complex relationships between binding and biological actions of these hormones.

Citing Articles

Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes.

Peckham H, Radziszewska A, Sikora J, de Gruijter N, Restuadi R, Kartawinata M J Exp Med. 2025; 222(4).

PMID: 40049222 PMC: 11893172. DOI: 10.1084/jem.20241253.


The In Vitro Cytotoxic Effect of Elesclomol on Breast Adenocarcinoma Cells Is Enhanced by Concurrent Treatment with Glycolytic Inhibitors.

Modica-Napolitano J, Murray M, Thibault J, Haley-Read J, Nixdorf L, Shanahan B Cancers (Basel). 2024; 16(23).

PMID: 39682240 PMC: 11639995. DOI: 10.3390/cancers16234054.


Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in mice.

Hjorth M, Egan C, Telles G, Pal M, Gallego-Ortega D, Fuller O J Sport Health Sci. 2024; 14:100991.

PMID: 39341495 PMC: 11809198. DOI: 10.1016/j.jshs.2024.100991.


Low ozone concentrations do not exert cytoprotective effects on tamoxifen-treated breast cancer cells .

Inguscio C, Carton F, Cisterna B, Rizzi M, Boccafoschi F, Tabaracci G Eur J Histochem. 2024; 68(3).

PMID: 39252536 PMC: 11445695. DOI: 10.4081/ejh.2024.4106.


Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines.

Pessino G, Lonati L, Scotti C, Calandra S, Cazzalini O, Iaria O Heliyon. 2024; 10(15):e35789.

PMID: 39170541 PMC: 11337022. DOI: 10.1016/j.heliyon.2024.e35789.